Sen. Lynwood Lewis

Co-sponsor HJ 716

Introduced · Virginia House of Delegates · Co-sponsor

Commending the Patrick Henry College international moot court team.

Introduced Jan 19, 2017 1 co-sponsor Track

Primary SB 1496

In committee · Virginia Senate · Lead sponsor

Virginia Alternative Energy and Coastal Protection Act; established, report.

In committee Jan 18, 2017 0 co-sponsors Track

Co-sponsor SB 1489

In committee · Virginia Senate · Co-sponsor

Workers' compensation; presumption that death or disease due to coal pneumoconiosis.

In committee Jan 18, 2017 1 co-sponsor Track

Co-sponsor HJ 684

Introduced · Virginia House of Delegates · Co-sponsor

Commending Robert C. Vaughan III.

Introduced Jan 12, 2017 1 co-sponsor Track

Co-sponsor SB 1408

In committee · Virginia Senate · Co-sponsor

Step therapy protocols; disclosures.

Requires health benefit plans that restrict the use of any prescription drug through the use of a step therapy protocol to have in place a clear, convenient, and expeditious process for a prescribing medical provider to request an override of such restrictions for a patient. A step therapy protocol is a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are medically appropriate for a particular covered person and are covered by a health benefit plan or that conditions coverage of a prescription medication on a patient first trying an alternative medication without success. The measure requires the granting of a step therapy protocol override if (i) the required prescription drug is contraindicated or will likely cause an adverse reaction or physical or mental harm to the patient; (ii) the required prescription drug is expected to be ineffective on the basis of the known relevant physical or mental characteristics of the covered person and the known characteristics of the prescription drug regimen; (iii) the covered person has tried the required prescription drug while under his current or a previous health benefit plan or another prescription drug in the same pharmacologic class or with the same mechanism of action and such prescription drug was discontinued due to lack of efficacy or effectiveness, diminished effect, or an adverse event; or (iv) the required prescription drug is not in the best interest of the covered person, based on medical appropriateness.

In committee Jan 11, 2017 1 co-sponsor Track

Co-sponsor SB 1269

In committee · Virginia Senate · Co-sponsor

Marijuana; decriminalization of simple possession.

In committee Jan 10, 2017 1 co-sponsor Track

Primary SB 1200

In committee · Virginia Senate · Lead sponsor

Voter identification requirements; repeal of photo identification requirements.

In committee Jan 10, 2017 0 co-sponsors Track

Primary SB 1206

In committee · Virginia Senate · Lead sponsor

Redistricting process.

In committee Jan 10, 2017 0 co-sponsors Track

Co-sponsor SB 1002

In committee · Virginia Senate · Co-sponsor

Absentee voting; no-excuse, in-person available 21 days prior to election.

In committee Jan 3, 2017 1 co-sponsor Track

Co-sponsor SB 841

In committee · Virginia Senate · Co-sponsor

Marijuana; possession or distribution for medical purposes, affirmative defense for treatment.

In committee Nov 17, 2016 1 co-sponsor Track